NLE Immune System & Immunologic Disorders — Autoimmune Disorders and HIV/AIDSExam Answer Templates

Marks

1

Topic

Overview of Immunity

Difficulty

easy

Template Id

T1

Examiner Tip

A one-mark definition question expects one clear, complete sentence. Do not write a paragraph — be precise and include the word 'antigen' to show clinical vocabulary.

Model Answer

Immunity is the body's ability to resist and defend against foreign substances (antigens) through specific and nonspecific defense mechanisms.

Question Type

very_short_answer

Answer Structure

• Line 1: State the definition — 'the body's ability to resist foreign substances/antigens' [1 mark]

Scoring Breakdown

Common Mark Deductions

• Vague answer such as 'immunity means being immune to diseases' without mentioning antigens or defense mechanisms
• Defining only one type of immunity instead of the general concept

Key Phrases To Include

• resist and defend
• foreign substances
• antigens
• defense mechanisms

Marks

1

Topic

Immunoglobulins

Difficulty

easy

Template Id

T2

Examiner Tip

Memorize the immunoglobulin-function pairings as a table. IgE = allergy/anaphylaxis is one of the most tested NLE immunology facts.

Model Answer

IgE mediates anaphylactic and allergic (Type I hypersensitivity) reactions by binding to mast cells and basophils, triggering degranulation and release of histamine.

Question Type

very_short_answer

Answer Structure

• Part 1: Name the immunoglobulin class — IgE [½ mark implied]
• Part 2: State its role — binds mast cells/basophils, triggers degranulation [½ mark implied]

Scoring Breakdown

Common Mark Deductions

• Writing IgG instead of IgE — this is a very common error
• Naming IgE but not explaining its mechanism or function

Key Phrases To Include

• IgE
• mast cells
• basophils
• degranulation
• histamine
• Type I hypersensitivity

Marks

2

Topic

Types of Acquired Immunity

Difficulty

easy

Template Id

T3

Examiner Tip

Examiners reward the contrast. Use the words 'slow but durable' and 'immediate but temporary' — these are the core differentiating phrases. Examples reinforce but do not substitute the definition.

Model Answer

Active immunity occurs when the body produces its own antibodies in response to an antigen (through infection or vaccination). It has a slow onset but is long-lasting because immunologic memory is created. Passive immunity occurs when ready-made antibodies are transferred to the individual (e.g., via the placenta, breast milk, or immunoglobulin injection). It has an immediate onset but is temporary because no immunologic memory is formed.

Question Type

short_answer

Answer Structure

• Line 1: Define active immunity — body makes own antibodies via infection or vaccine; slow onset, long-lasting with memory [1 mark]
• Line 2: Define passive immunity — receives ready-made antibodies externally; immediate onset, temporary, no memory [1 mark]

Scoring Breakdown

Common Mark Deductions

• Confusing the onset — stating passive immunity is slow or active immunity is immediate
• Not mentioning the concept of immunologic memory as the key reason for duration difference
• Giving only examples without the conceptual definition

Key Phrases To Include

• body produces own antibodies
• immunologic memory
• slow onset, long-lasting
• ready-made antibodies transferred
• immediate but temporary
• no memory formed

Marks

2

Topic

Types of Acquired Immunity

Difficulty

medium

Template Id

T4

Examiner Tip

Natural = happens naturally (infection or maternal transfer). Artificial = human intervention (needle or injection). This distinction earns or loses marks consistently.

Model Answer

Natural active immunity examples: (1) immunity acquired after recovering from chickenpox, (2) immunity acquired after measles infection. Artificial passive immunity examples: (1) tetanus immunoglobulin injection given after a wound, (2) rabies immunoglobulin given after an animal bite.

Question Type

short_answer

Answer Structure

• Part 1: Two correct examples of natural active immunity — actual infection-derived immunity [1 mark]
• Part 2: Two correct examples of artificial passive immunity — immunoglobulin/antiserum injection [1 mark]

Scoring Breakdown

Common Mark Deductions

• Confusing artificial active (vaccination) with natural active (infection) — vaccines are artificial, not natural
• Listing breast milk as artificial passive — it is natural passive because the mother naturally transfers IgA

Key Phrases To Include

• post-infection immunity
• immunoglobulin injection
• tetanus immunoglobulin
• rabies immunoglobulin
• antivenom

Marks

2

Topic

Four Types of Hypersensitivity Reactions

Difficulty

medium

Template Id

T5

Examiner Tip

Use the ACID mnemonic in your answer — write it in parentheses. It shows the examiner you have a systematic framework and rarely fails to be correct.

Model Answer

Type I (Anaphylactic/Allergic): IgE-mediated; reaction within minutes; examples include anaphylaxis and allergic rhinitis. Type II (Cytotoxic): IgG/IgM antibodies target cell-surface antigens causing cell destruction; example is ABO transfusion reaction. Type III (Immune Complex): Antigen-antibody complexes deposit in tissues causing inflammation; examples include SLE and glomerulonephritis. Type IV (Delayed): T-lymphocyte mediated, not antibody mediated; reaction in 24–72 hours; examples include PPD skin test reaction and contact dermatitis.

Question Type

short_answer

Answer Structure

• Type I: IgE-mediated, immediate, allergic/anaphylactic [½ mark]
• Type II: IgG/IgM, cytotoxic/cell destruction [½ mark]
• Type III: Immune complex deposition, inflammation [½ mark]
• Type IV: T-cell mediated, delayed 24-72 hours [½ mark]

Scoring Breakdown

Common Mark Deductions

• Stating Type IV is antibody-mediated — it is the ONLY type that is NOT antibody-mediated
• Not specifying the 24-72 hour timing for Type IV
• Confusing Type II and Type III mechanisms

Key Phrases To Include

• IgE-mediated
• IgG/IgM cytotoxic
• immune complex deposition
• T-lymphocyte mediated
• 24-72 hours delayed
• ACID mnemonic

Marks

3

Topic

Type III Hypersensitivity

Difficulty

medium

Template Id

T6

Examiner Tip

For Type III questions, the three-step mechanism earns three marks: (1) complex formation, (2) deposition, (3) complement activation and inflammation. Write them in order.

Model Answer

SLE involves Type III (Immune Complex) Hypersensitivity. The immunologic mechanism is as follows: In SLE, the body produces autoantibodies against self-antigens (such as double-stranded DNA). These autoantibodies combine with the self-antigens to form antigen-antibody immune complexes. These immune complexes circulate in the bloodstream and deposit in various tissues — including the kidneys, joints, skin, and blood vessels. The deposited complexes activate the complement system, triggering an inflammatory cascade that causes tissue damage, resulting in the multi-system manifestations of SLE (nephritis, arthritis, rash, vasculitis).

Question Type

short_answer

Answer Structure

• Statement 1: Identify the type — Type III Immune Complex Hypersensitivity [1 mark]
• Statement 2: Explain autoantibody formation against self-antigens and immune complex formation [1 mark]
• Statement 3: Describe immune complex deposition in tissues and complement activation causing inflammation/tissue damage [1 mark]

Scoring Breakdown

Common Mark Deductions

• Identifying as Type II instead of Type III — a common confusion
• Describing only that antibodies attack cells (Type II mechanism) rather than complex deposition
• Failing to mention complement activation as the inflammatory trigger

Key Phrases To Include

• Type III immune complex
• autoantibodies
• antigen-antibody complexes
• complement activation
• tissue deposition
• inflammation
• multi-system damage

Marks

3

Topic

Type I Hypersensitivity — Pathophysiology

Difficulty

hard

Template Id

T7

Examiner Tip

Structure this as a two-phase narrative: sensitization then re-exposure. The word 'degranulation' is a must — it is the cellular mechanism that separates a detailed answer from a superficial one.

Model Answer

Type I hypersensitivity follows a two-phase process: sensitization and re-exposure. During sensitization (first exposure), the allergen is processed by antigen-presenting cells, which stimulate B lymphocytes to produce allergen-specific IgE antibodies. These IgE antibodies bind to receptors on mast cells and basophils, coating them — the person is now sensitized but shows no symptoms. Upon re-exposure to the same allergen, the allergen cross-links the IgE antibodies already bound to mast cells and basophils. This triggers degranulation — the mast cells and basophils release preformed mediators including histamine, leukotrienes, and prostaglandins. These mediators cause vasodilation, increased capillary permeability, bronchoconstriction, and smooth muscle contraction, producing the clinical manifestations of urticaria, angioedema, bronchospasm, and in severe cases, anaphylaxis.

Question Type

short_answer

Answer Structure

• Phase 1 — Sensitization: First exposure → IgE production → IgE binds to mast cells/basophils [1 mark]
• Phase 2 — Re-exposure: Allergen cross-links IgE → mast cell/basophil degranulation → mediator release (histamine, leukotrienes) [1 mark]
• Phase 3 — Effects: Vasodilation, bronchoconstriction, increased permeability → clinical manifestations [1 mark]

Scoring Breakdown

Common Mark Deductions

• Skipping the sensitization phase and only describing re-exposure
• Not mentioning degranulation as the key cellular event
• Listing only histamine without acknowledging other mediators (leukotrienes, prostaglandins)

Key Phrases To Include

• sensitization
• IgE antibodies
• mast cells
• basophils
• degranulation
• histamine
• vasodilation
• bronchoconstriction
• re-exposure
• increased capillary permeability

Marks

3

Topic

Anaphylaxis — Emergency Management

Difficulty

hard

Template Id

T8

Examiner Tip

In anaphylaxis management questions, epinephrine must ALWAYS be the first intervention named after removing the trigger. Any answer that places antihistamines first will lose at least one mark regardless of other content.

Model Answer

This patient is experiencing anaphylaxis — a life-threatening Type I hypersensitivity reaction. Immediate priority management is as follows: First, STOP the penicillin infusion immediately to remove the causative agent. Second, call for emergency assistance and administer epinephrine 0.3–0.5 mg of 1:1000 (1 mg/mL) solution intramuscularly into the anterolateral thigh (vastus lateralis) — this is the FIRST-LINE drug and must not be delayed. Third, maintain a patent airway: administer high-flow oxygen, position the patient supine with legs elevated (unless dyspneic), prepare for possible intubation. Adjunct medications include diphenhydramine (antihistamine), hydrocortisone (corticosteroid), and nebulized salbutamol for bronchospasm. Monitor vital signs and oxygen saturation continuously, establish IV access for fluid resuscitation with normal saline, and observe for biphasic reaction.

Question Type

case_study

Answer Structure

• Step 1: Remove the trigger — stop penicillin infusion immediately [1 mark]
• Step 2: Administer epinephrine — state drug, dose (0.3-0.5 mg), concentration (1:1000), route (IM), site (anterolateral thigh) as first-line [1 mark]
• Step 3: Airway management — oxygen, positioning, IV access, adjunct medications, continuous monitoring [1 mark]

Scoring Breakdown

Common Mark Deductions

• Mentioning antihistamine (diphenhydramine) as the FIRST drug instead of epinephrine — this is the most heavily penalized error
• Stating epinephrine IV 1:1000 — the 1:1000 concentration is IM only; IV anaphylaxis epinephrine uses a different protocol
• Not mentioning the anterolateral thigh as the preferred IM injection site
• Forgetting to mention monitoring for biphasic reaction

Key Phrases To Include

• anaphylaxis
• stop the trigger
• epinephrine 0.3-0.5 mg
• 1:1000 concentration
• intramuscularly
• anterolateral thigh
• high-flow oxygen
• diphenhydramine
• hydrocortisone
• biphasic reaction
• normal saline

Marks

3

Topic

Anaphylaxis — Epinephrine

Difficulty

hard

Template Id

T9

Examiner Tip

The concentration distinction (1:1000 IM vs 1:10,000 IV) is a classic NLE trap. State it explicitly in your answer — examiners award marks for demonstrating awareness of this clinical safety point.

Model Answer

Epinephrine (adrenaline) is the FIRST-LINE, life-saving drug in anaphylaxis. Dose and route: Administer 0.3–0.5 mg of 1:1000 (1 mg/mL) concentration intramuscularly (IM) into the anterolateral thigh (vastus lateralis) for adults; the pediatric dose is 0.01 mg/kg IM up to 0.3 mg. It may be repeated every 5–15 minutes if the patient does not respond. Note: the 1:10,000 IV concentration is reserved for cardiac arrest — do NOT confuse the two concentrations. Mechanism of action: Epinephrine is a sympathomimetic (adrenergic) agonist that acts on alpha-1 receptors to cause vasoconstriction, raising blood pressure and reversing distributive shock. It acts on beta-2 receptors to cause bronchodilation, relieving bronchoconstriction and airway obstruction. It also reduces vascular permeability, decreasing angioedema and laryngeal edema. Adjuncts (antihistamines, corticosteroids) are given after epinephrine but do not replace it.

Question Type

short_answer

Answer Structure

• Part 1: State epinephrine as first-line drug, with correct dose (0.3-0.5 mg), concentration (1:1000), route (IM), site (anterolateral thigh) [1 mark]
• Part 2: Explain alpha-1 mechanism — vasoconstriction → raises BP, reverses shock; and note the concentration difference with IV preparation [1 mark]
• Part 3: Explain beta-2 mechanism — bronchodilation, reduces laryngeal edema and vascular permeability; note adjunct status of other drugs [1 mark]

Scoring Breakdown

Common Mark Deductions

• Confusing 1:1000 (IM for anaphylaxis) with 1:10,000 (IV for cardiac arrest)
• Stating epinephrine should be given IV for anaphylaxis without the appropriate dilution protocol
• Not explaining the dual receptor mechanism (alpha and beta)

Key Phrases To Include

• first-line drug
• 0.3-0.5 mg
• 1:1000 concentration
• intramuscularly
• anterolateral thigh
• alpha-1 vasoconstriction
• beta-2 bronchodilation
• 1:10,000 for cardiac arrest
• reduces laryngeal edema

Marks

2

Topic

Type II and Type III Hypersensitivity

Difficulty

medium

Template Id

T10

Examiner Tip

The key difference is WHERE the antibody acts: Type II acts directly ON cells (cell surface); Type III acts as circulating complexes that DEPOSIT between cells (tissues). This location concept is the distinction examiners test.

Model Answer

Type II (Cytotoxic) Hypersensitivity: Mediated by IgG or IgM antibodies that bind directly to antigens on the surface of the patient's own cells. This triggers complement activation and phagocytosis, resulting in cell destruction. Clinical examples include ABO-incompatible blood transfusion reaction, Rh hemolytic disease of the newborn, autoimmune hemolytic anemia, and myasthenia gravis. Type III (Immune Complex) Hypersensitivity: Mediated by antigen-antibody (immune) complexes that form in circulation and deposit in tissues and vessel walls. This activates complement and produces widespread inflammation. Clinical examples include systemic lupus erythematosus (SLE), post-streptococcal glomerulonephritis, rheumatoid arthritis, and serum sickness.

Question Type

short_answer

Answer Structure

• Type II: IgG/IgM, binds to cell surface antigens, cell destruction via complement, examples (ABO reaction, hemolytic disease) [1 mark]
• Type III: Immune complexes formed and deposited in tissues, complement activation, widespread inflammation, examples (SLE, glomerulonephritis) [1 mark]

Scoring Breakdown

Common Mark Deductions

• Mixing up the mechanisms — describing complex deposition for Type II or cell-surface antibodies for Type III
• Using wrong clinical examples (e.g., placing PPD test under Type II or III instead of Type IV)

Key Phrases To Include

• IgG/IgM
• cell-surface antigens
• cell destruction
• complement activation
• immune complex deposition
• tissue inflammation
• ABO transfusion reaction
• SLE
• glomerulonephritis

Marks

1

Topic

Type IV Hypersensitivity

Difficulty

easy

Template Id

T11

Examiner Tip

Remember: Type IV is the 'odd one out' — the only non-antibody type. If a question says 'delayed' or '24-72 hours' or 'T-cell,' it is always Type IV. This is a reliable NLE pattern.

Model Answer

Type IV (Delayed) hypersensitivity is a T-lymphocyte–mediated reaction that occurs 24–72 hours after antigen exposure. It is the only hypersensitivity type NOT mediated by antibodies. Clinical examples relevant to nursing: (1) the tuberculin (PPD/Mantoux) skin test reaction, and (2) contact dermatitis from latex gloves.

Question Type

very_short_answer

Answer Structure

• Part 1: State T-lymphocyte mediation and 24-72 hour delay — no antibodies involved [½ mark implied]
• Part 2: Two valid clinical examples from nursing context [½ mark implied]

Scoring Breakdown

Common Mark Deductions

• Stating Type IV is mediated by IgE or any antibody — this is factually wrong and loses the mark
• Giving only one example when two are asked
• Not mentioning the 24-72 hour delay, which is the defining characteristic

Key Phrases To Include

• T-lymphocyte mediated
• 24-72 hours
• NOT antibody mediated
• PPD/Mantoux test
• contact dermatitis

Marks

5

Topic

Latex Allergy

Difficulty

hard

Template Id

T12

Examiner Tip

Five-mark latex allergy questions nearly always expect the two-type comparison, the specific high-risk groups, and the 'first case of the day' scheduling rule. If you miss any one of these three elements, you risk losing 1-2 marks regardless of the quality of the rest of the answer.

Model Answer

Latex allergy is an important occupational and patient safety concern in Philippine hospitals and healthcare facilities, given the widespread use of latex gloves and equipment. TYPES OF LATEX REACTIONS: Latex allergy presents in two distinct forms. (1) Type IV Delayed Contact Dermatitis — the most common form; it is a T-lymphocyte-mediated (not antibody-mediated) reaction to chemical additives in latex products. Symptoms are eczematous skin changes (redness, itching, blisters) occurring 24–48 hours after contact. (2) Type I Immediate IgE-Mediated Reaction — the more serious and potentially life-threatening form; IgE antibodies bind to latex proteins on mast cells. Re-exposure causes immediate degranulation and histamine release. Manifestations progress from urticaria and rhinitis to bronchospasm and anaphylaxis. HIGH-RISK POPULATIONS: (1) Healthcare workers with prolonged glove exposure; (2) patients with spina bifida and those who have undergone multiple surgeries — due to repeated mucosal exposure to latex via catheterization and surgical procedures; (3) rubber industry workers; and (4) individuals with latex-food cross-reactivity — cross-reactions occur with banana, avocado, kiwi, and chestnut (the 'BAKC' foods). NURSING MANAGEMENT: (1) Assess and identify at-risk patients on admission — allergy history must include latex; (2) establish and maintain a LATEX-FREE ENVIRONMENT — use non-latex gloves and latex-free equipment and supplies; (3) for surgical patients, schedule latex-sensitive patients as the FIRST CASE OF THE DAY to minimize airborne latex particles that accumulate during the day; (4) place a latex allergy identification band on the patient and post signage at the bedside and patient's chart; (5) keep emergency anaphylaxis equipment readily available (epinephrine auto-injector, oxygen, IV supplies); (6) teach the patient to identify latex-containing products in daily life, carry medical-alert identification, and recognize early allergic symptoms.

Question Type

long_answer

Answer Structure

• Introduction: Significance in healthcare context [½ mark]
• Type IV delayed contact dermatitis — mechanism, timing, manifestations [1 mark]
• Type I immediate IgE-mediated reaction — mechanism, progression to anaphylaxis [1 mark]
• High-risk populations — healthcare workers, spina bifida patients, multiple surgery patients, latex-food cross-reactivity (BAKC foods) [1 mark]
• Nursing management — latex-free environment, first case scheduling, identification band, emergency preparedness, patient teaching [1.5 marks]

Scoring Breakdown

Common Mark Deductions

• Describing only one type of latex reaction — must address both Type IV and Type I for full marks
• Forgetting to mention spina bifida as the classic high-risk patient group
• Not specifying the 'first case of the day' scheduling — this is a highly specific and frequently tested nursing intervention
• Omitting the latex-food cross-reactivity foods
• Writing generic allergy nursing care without latex-specific interventions

Key Phrases To Include

• latex-free environment
• Type IV delayed contact dermatitis
• Type I IgE-mediated anaphylaxis
• spina bifida
• multiple prior surgeries
• first case of the day
• banana avocado kiwi chestnut
• identification band
• emergency equipment
• airborne latex particles

Marks

5

Topic

Immunodeficiency — Nursing Management

Difficulty

hard

Template Id

T13

Examiner Tip

Five-mark nursing management questions are graded on breadth AND depth. Use a structured format with headings (Assessment, Precautions, Pharmacology, Teaching) so the examiner can clearly see each component deserving a mark. Answers without clear structure often miss partial marks even when the content is present.

Model Answer

Immunodeficiency — whether primary (congenital, such as SCID) or secondary (acquired, such as HIV/AIDS, chemotherapy-induced neutropenia) — leaves the patient highly susceptible to infection. Nursing management focuses on infection prevention, early detection, and patient education. ASSESSMENT: Continuously monitor for signs of infection. In immunodeficient patients, the classic signs of infection (swelling, pus, redness) may be absent because of the impaired immune response; FEVER may be the only presenting sign. Report any temperature elevation promptly — treat fever as infection until proven otherwise. PROTECTIVE (NEUTROPENIC) PRECAUTIONS — the cornerstone of immunodeficiency care: (1) Meticulous hand hygiene — the single most effective infection-prevention measure; follow the WHO 5 Moments of Hand Hygiene; (2) Place the patient in a PRIVATE ROOM (reverse isolation/protective environment) with positive-pressure airflow when available (especially for SCID and bone marrow transplant patients); (3) Restrict visitors — exclude individuals with active infections, colds, or who have recently received live vaccines; (4) Dietary precautions — avoid raw fruits, raw vegetables, and raw meats (neutropenic diet) because of microbial contamination; no fresh-cut flowers or standing water in the room (reservoir for Pseudomonas and other pathogens); (5) Strict aseptic technique for all invasive procedures (IV insertion, catheterization, wound care); (6) LIVE VACCINES ARE CONTRAINDICATED in significant immunodeficiency — they can cause vaccine-strain infection. Killed/inactivated vaccines may be given as indicated. PHARMACOLOGIC MANAGEMENT: Administer prescribed antimicrobials, antifungals, or antivirals for prophylaxis or active infection. For antibody deficiencies (e.g., Bruton agammaglobulinemia), administer intravenous immunoglobulin (IVIG) — infuse slowly at the ordered rate, monitor for infusion reactions (chills, fever, hypotension), and keep emergency equipment available. PATIENT AND FAMILY TEACHING: (1) Teach the importance of strict hand hygiene at home; (2) Avoid crowds and persons with infections; (3) Report fever, unusual fatigue, sores, or other early infection symptoms immediately to a health provider; (4) Maintain adequate nutrition to support immune function; (5) Comply with follow-up appointments and laboratory monitoring (CBC with differential for absolute neutrophil count); (6) Avoid uncooked foods and maintain a clean home environment.

Question Type

long_answer

Answer Structure

• Introduction: Context of immunodeficiency (primary vs secondary examples) [½ mark]
• Assessment — fever as primary sign, continuous monitoring [½ mark]
• Protective/neutropenic precautions — hand hygiene, private room, visitor restriction, neutropenic diet, no flowers/standing water [1.5 marks]
• Vaccine consideration — live vaccines contraindicated [½ mark]
• Pharmacologic management — IVIG administration and monitoring [1 mark]
• Patient and family teaching — home infection prevention, reporting, nutrition, follow-up [1 mark]

Scoring Breakdown

Common Mark Deductions

• Focusing only on hand hygiene without addressing dietary and environmental restrictions
• Not mentioning that fever may be the only sign of infection in immunocompromised patients
• Forgetting the contraindication of live vaccines — a highly specific and examinable point
• Not including patient/family teaching as a distinct component of the answer

Key Phrases To Include

• fever as primary sign
• protective/neutropenic precautions
• meticulous hand hygiene
• private room
• reverse isolation
• neutropenic diet
• no raw fruits/vegetables
• no fresh flowers or standing water
• live vaccines contraindicated
• IVIG
• infusion reaction monitoring
• patient teaching

Marks

2

Topic

Immunoglobulins

Difficulty

medium

Template Id

T14

Examiner Tip

This is a classic NLE immunology comparison. Remember: M comes before G alphabetically, just as IgM appears before IgG in the immune response. IgG = 'Goes' across the placenta. These memory tricks prevent transposition errors.

Model Answer

IgM is the first antibody produced during a PRIMARY (acute, initial) infection. It is the largest immunoglobulin and appears early in the immune response, making it a useful diagnostic marker for acute or recent infection. IgM does NOT cross the placenta. IgG is the most abundant immunoglobulin and is primarily responsible for the SECONDARY (memory/anamnestic) immune response — the rapid, stronger antibody response upon re-exposure to an antigen. IgG crosses the placenta, providing passive immunity to the newborn (natural passive immunity) for the first few months of life.

Question Type

short_answer

Answer Structure

• IgM: first antibody in primary infection, largest, acute infection marker, does not cross placenta [1 mark]
• IgG: most abundant, secondary/memory response, crosses placenta for newborn protection [1 mark]

Scoring Breakdown

Common Mark Deductions

• Confusing IgM and IgG roles — stating IgG is first in primary infection or IgM crosses the placenta
• Not differentiating between primary and secondary responses in relation to each immunoglobulin

Key Phrases To Include

• IgM first in primary infection
• largest immunoglobulin
• acute infection marker
• does not cross placenta
• IgG most abundant
• secondary/memory response
• crosses placenta
• newborn passive immunity

Marks

3

Topic

Types of Acquired Immunity — Clinical Application

Difficulty

hard

Template Id

T15

Examiner Tip

Clinical application questions like this reward students who connect the theory to practical reasoning. Always name the immunity type explicitly, then explain the rationale in terms of onset and duration. This shows higher-order thinking that NLE examiners reward.

Model Answer

This is an excellent clinical question that demonstrates the complementary roles of active and passive immunization. The tetanus TOXOID vaccine stimulates the patient's own immune system to produce antibodies against tetanus toxin — this is ARTIFICIAL ACTIVE IMMUNITY. However, it takes 2–4 weeks for the body to mount a protective antibody response (slow onset). If the patient currently has a contaminated wound, the bacteria can produce toxin and cause disease BEFORE the vaccine has time to work. This is why the tetanus IMMUNOGLOBULIN (TIG) is given simultaneously — TIG provides ready-made pre-formed antibodies that are IMMEDIATELY available to neutralize any tetanus toxin already present — this is ARTIFICIAL PASSIVE IMMUNITY. The two are NOT contradictory but synergistic: TIG provides immediate (but temporary) protection while the vaccine builds long-lasting (but slow) immunity. They are injected at DIFFERENT SITES to prevent the ready-made antibodies from neutralizing the live toxoid before it can stimulate an immune response. This strategy is called simultaneous passive-active immunization.

Question Type

case_study

Answer Structure

• Part 1: Tetanus toxoid = artificial active immunity — slow onset but long-lasting; body makes own antibodies [1 mark]
• Part 2: TIG = artificial passive immunity — immediate onset but temporary; ready-made antibodies to bridge the gap [1 mark]
• Part 3: Rationale for simultaneous use — TIG covers the window period; injected at different sites to avoid neutralizing the toxoid [1 mark]

Scoring Breakdown

Common Mark Deductions

• Not naming the types of immunity explicitly (active/passive, artificial)
• Failing to explain WHY different injection sites are used
• Not addressing the 'window period' concept — the gap between vaccination and protective immunity

Key Phrases To Include

• artificial active immunity
• artificial passive immunity
• slow onset long-lasting
• immediate but temporary
• different injection sites
• bridge the window period
• simultaneous passive-active immunization
• ready-made antibodies